Ignite Creation Date:
2025-12-24 @ 6:48 PM
Ignite Modification Date:
2025-12-27 @ 11:23 AM
Study NCT ID:
NCT00114257
Status:
COMPLETED
Last Update Posted:
2013-02-11
First Post:
2005-06-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-05
Start Date Type:
None
Primary Completion Date:
2006-09
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2005-06-13
First Submit QC Date:
None
Study First Post Date:
2005-06-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-02-08
Last Update Post Date:
2013-02-11
Last Update Post Date Type:
ESTIMATED